| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Charcot-Marie-Tooth Disease | 24 | 2024 | 192 | 3.970 |
Why?
|
| Connexins | 13 | 2023 | 78 | 1.570 |
Why?
|
| Myelin Sheath | 6 | 2016 | 149 | 1.010 |
Why?
|
| Pharmacogenetics | 6 | 2023 | 260 | 0.930 |
Why?
|
| Optic Nerve Diseases | 2 | 2022 | 103 | 0.920 |
Why?
|
| Schwann Cells | 7 | 2016 | 75 | 0.880 |
Why?
|
| Gap Junctions | 4 | 2011 | 43 | 0.830 |
Why?
|
| Mutation | 32 | 2024 | 15179 | 0.760 |
Why?
|
| Axons | 8 | 2016 | 403 | 0.750 |
Why?
|
| Optic Nerve | 1 | 2021 | 133 | 0.730 |
Why?
|
| Sequence Analysis, DNA | 21 | 2023 | 2483 | 0.660 |
Why?
|
| Cytochrome P-450 CYP2D6 | 3 | 2022 | 43 | 0.570 |
Why?
|
| Tomography, Optical Coherence | 1 | 2021 | 501 | 0.570 |
Why?
|
| Neuroglia | 2 | 2008 | 223 | 0.540 |
Why?
|
| Thyroid Carcinoma, Anaplastic | 3 | 2024 | 259 | 0.530 |
Why?
|
| Genotype | 19 | 2023 | 4109 | 0.520 |
Why?
|
| Nerve Tissue Proteins | 5 | 2008 | 1491 | 0.500 |
Why?
|
| Genetic Testing | 9 | 2024 | 1589 | 0.500 |
Why?
|
| Sodium Chloride Symporter Inhibitors | 3 | 2018 | 31 | 0.480 |
Why?
|
| Alleles | 14 | 2023 | 2437 | 0.470 |
Why?
|
| Hydrochlorothiazide | 3 | 2018 | 61 | 0.460 |
Why?
|
| High-Throughput Nucleotide Sequencing | 8 | 2024 | 2291 | 0.460 |
Why?
|
| Demyelinating Diseases | 4 | 2016 | 77 | 0.450 |
Why?
|
| Polymorphism, Single Nucleotide | 13 | 2023 | 4549 | 0.450 |
Why?
|
| Blood Pressure | 5 | 2018 | 1467 | 0.430 |
Why?
|
| Phenotype | 18 | 2023 | 6295 | 0.430 |
Why?
|
| Connexin 43 | 2 | 2011 | 46 | 0.420 |
Why?
|
| Neurofilament Proteins | 2 | 2009 | 30 | 0.420 |
Why?
|
| Sciatic Nerve | 7 | 2005 | 112 | 0.410 |
Why?
|
| Genes, Dominant | 6 | 2020 | 331 | 0.410 |
Why?
|
| Antihypertensive Agents | 4 | 2018 | 395 | 0.410 |
Why?
|
| Evolution, Molecular | 13 | 2015 | 834 | 0.410 |
Why?
|
| Cytochrome P-450 CYP2A6 | 3 | 2022 | 18 | 0.400 |
Why?
|
| Potassium Channels, Voltage-Gated | 2 | 2001 | 64 | 0.400 |
Why?
|
| Myelin P0 Protein | 6 | 2022 | 27 | 0.380 |
Why?
|
| Peripheral Nervous System Diseases | 2 | 2009 | 393 | 0.380 |
Why?
|
| Astrocytes | 2 | 2011 | 368 | 0.360 |
Why?
|
| Genetic Variation | 9 | 2020 | 2086 | 0.360 |
Why?
|
| Pedigree | 16 | 2022 | 1890 | 0.360 |
Why?
|
| Genes, Modifier | 2 | 2019 | 11 | 0.350 |
Why?
|
| Scoliosis | 2 | 2023 | 139 | 0.330 |
Why?
|
| Chromosome Mapping | 12 | 2018 | 1471 | 0.320 |
Why?
|
| Humans | 106 | 2024 | 261506 | 0.310 |
Why?
|
| Cell Membrane | 4 | 2008 | 850 | 0.310 |
Why?
|
| Pharmacogenomic Variants | 2 | 2018 | 29 | 0.310 |
Why?
|
| Mutation, Missense | 6 | 2023 | 1152 | 0.300 |
Why?
|
| Chromosomes, Human, Pair 12 | 2 | 2006 | 185 | 0.300 |
Why?
|
| Hearing Loss | 3 | 2015 | 153 | 0.300 |
Why?
|
| Nervous System | 1 | 2008 | 165 | 0.300 |
Why?
|
| Thyroid Neoplasms | 3 | 2024 | 1866 | 0.300 |
Why?
|
| Genomics | 9 | 2024 | 2738 | 0.300 |
Why?
|
| Candida albicans | 4 | 2000 | 175 | 0.290 |
Why?
|
| Nicotine | 2 | 2020 | 244 | 0.290 |
Why?
|
| Genome | 6 | 2014 | 672 | 0.290 |
Why?
|
| Synteny | 5 | 2016 | 87 | 0.280 |
Why?
|
| Polyneuropathies | 2 | 2016 | 28 | 0.280 |
Why?
|
| Protein Prenylation | 1 | 2005 | 20 | 0.270 |
Why?
|
| Peripheral Nervous System | 3 | 2022 | 42 | 0.270 |
Why?
|
| Male | 60 | 2024 | 123000 | 0.270 |
Why?
|
| Genes, Insect | 3 | 2015 | 131 | 0.270 |
Why?
|
| Cytoskeletal Proteins | 4 | 2001 | 492 | 0.260 |
Why?
|
| Hypertension | 4 | 2018 | 1503 | 0.260 |
Why?
|
| Animals | 39 | 2023 | 59536 | 0.260 |
Why?
|
| Ranvier's Nodes | 3 | 2001 | 68 | 0.250 |
Why?
|
| Phylogeny | 7 | 2015 | 826 | 0.250 |
Why?
|
| Neural Conduction | 6 | 2017 | 112 | 0.250 |
Why?
|
| Genome, Insect | 3 | 2016 | 98 | 0.240 |
Why?
|
| Cell Communication | 5 | 2017 | 509 | 0.240 |
Why?
|
| Genetic Association Studies | 5 | 2023 | 1084 | 0.240 |
Why?
|
| Base Sequence | 17 | 2022 | 4917 | 0.240 |
Why?
|
| Psychodidae | 1 | 2023 | 12 | 0.230 |
Why?
|
| Phlebotomus | 1 | 2023 | 15 | 0.230 |
Why?
|
| Gene Expression Profiling | 7 | 2018 | 5159 | 0.230 |
Why?
|
| Exons | 6 | 2022 | 1328 | 0.230 |
Why?
|
| Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 1 | 2022 | 4 | 0.230 |
Why?
|
| HLA-B Antigens | 3 | 2008 | 57 | 0.230 |
Why?
|
| Leishmania | 1 | 2023 | 24 | 0.230 |
Why?
|
| Leishmaniasis, Cutaneous | 1 | 2023 | 46 | 0.230 |
Why?
|
| Female | 55 | 2024 | 141928 | 0.230 |
Why?
|
| Molecular Sequence Data | 16 | 2015 | 6089 | 0.220 |
Why?
|
| Nicotinic Agonists | 1 | 2024 | 113 | 0.220 |
Why?
|
| Genetic Predisposition to Disease | 7 | 2016 | 5539 | 0.220 |
Why?
|
| Young Adult | 21 | 2022 | 21445 | 0.220 |
Why?
|
| Kidney Transplantation | 3 | 2017 | 755 | 0.220 |
Why?
|
| Disease Models, Animal | 5 | 2022 | 7222 | 0.220 |
Why?
|
| Ring Chromosomes | 1 | 2022 | 15 | 0.220 |
Why?
|
| Exome | 5 | 2016 | 1239 | 0.220 |
Why?
|
| Graft Survival | 4 | 2017 | 1062 | 0.220 |
Why?
|
| Pharmacogenomic Testing | 2 | 2022 | 46 | 0.220 |
Why?
|
| DNA Mutational Analysis | 8 | 2016 | 2283 | 0.220 |
Why?
|
| Genome, Human | 6 | 2019 | 1869 | 0.220 |
Why?
|
| Cytochrome P-450 CYP2C8 | 1 | 2022 | 5 | 0.210 |
Why?
|
| Cytochrome P-450 CYP2C9 | 1 | 2022 | 7 | 0.210 |
Why?
|
| Cytochrome P-450 CYP2C19 | 1 | 2022 | 22 | 0.210 |
Why?
|
| Neurology | 1 | 2024 | 113 | 0.210 |
Why?
|
| GTP Phosphohydrolases | 3 | 2020 | 336 | 0.210 |
Why?
|
| Nephritis, Hereditary | 1 | 2022 | 47 | 0.210 |
Why?
|
| Mitochondrial Proteins | 3 | 2020 | 369 | 0.210 |
Why?
|
| Hematuria | 1 | 2022 | 85 | 0.210 |
Why?
|
| Membrane Proteins | 4 | 2012 | 2819 | 0.210 |
Why?
|
| Middle Aged | 37 | 2022 | 86204 | 0.210 |
Why?
|
| Papilledema | 1 | 2022 | 85 | 0.200 |
Why?
|
| Neurons | 2 | 2017 | 2287 | 0.200 |
Why?
|
| Atenolol | 2 | 2018 | 42 | 0.200 |
Why?
|
| Adult | 37 | 2024 | 77950 | 0.200 |
Why?
|
| Microvilli | 1 | 2001 | 83 | 0.200 |
Why?
|
| Nerve Fibers | 1 | 2021 | 106 | 0.190 |
Why?
|
| Phosphoproteins | 3 | 2017 | 1152 | 0.190 |
Why?
|
| Microfilament Proteins | 2 | 2017 | 487 | 0.190 |
Why?
|
| Smoking Cessation | 2 | 2024 | 712 | 0.190 |
Why?
|
| Sural Nerve | 4 | 2016 | 54 | 0.190 |
Why?
|
| Cytochrome P-450 CYP2B6 | 1 | 2020 | 22 | 0.190 |
Why?
|
| Chlorthalidone | 2 | 2017 | 26 | 0.190 |
Why?
|
| Mosaicism | 1 | 2022 | 272 | 0.190 |
Why?
|
| Mice, Knockout | 5 | 2022 | 5710 | 0.190 |
Why?
|
| Diabetic Neuropathies | 1 | 2001 | 101 | 0.190 |
Why?
|
| Mice | 17 | 2023 | 34495 | 0.190 |
Why?
|
| Urinary Bladder Neoplasms | 5 | 2019 | 2341 | 0.180 |
Why?
|
| Blood Proteins | 1 | 2001 | 294 | 0.180 |
Why?
|
| High-Throughput Screening Assays | 1 | 2021 | 216 | 0.180 |
Why?
|
| Chromosomes | 2 | 2015 | 244 | 0.180 |
Why?
|
| Age of Onset | 4 | 2020 | 827 | 0.180 |
Why?
|
| Myelin Proteins | 4 | 2019 | 90 | 0.170 |
Why?
|
| Nervous System Diseases | 1 | 2024 | 500 | 0.170 |
Why?
|
| Silver-Russell Syndrome | 1 | 2019 | 2 | 0.170 |
Why?
|
| Patch-Clamp Techniques | 4 | 2017 | 388 | 0.170 |
Why?
|
| Cell Differentiation | 2 | 2008 | 4078 | 0.170 |
Why?
|
| Autopsy | 2 | 2016 | 173 | 0.170 |
Why?
|
| Bestrophins | 1 | 2018 | 4 | 0.170 |
Why?
|
| Urothelium | 2 | 2019 | 254 | 0.170 |
Why?
|
| Polymorphism, Genetic | 5 | 2018 | 1450 | 0.170 |
Why?
|
| Facies | 1 | 2019 | 149 | 0.160 |
Why?
|
| Foot | 1 | 2019 | 104 | 0.160 |
Why?
|
| GTPase-Activating Proteins | 1 | 2019 | 126 | 0.160 |
Why?
|
| Arrhythmogenic Right Ventricular Dysplasia | 2 | 2010 | 29 | 0.160 |
Why?
|
| Adolescent | 19 | 2020 | 31252 | 0.160 |
Why?
|
| Karyotyping | 2 | 2022 | 1022 | 0.160 |
Why?
|
| Disease Progression | 5 | 2022 | 6682 | 0.160 |
Why?
|
| Renin | 1 | 2018 | 92 | 0.160 |
Why?
|
| Genes, Fungal | 3 | 2000 | 84 | 0.160 |
Why?
|
| Muscle Weakness | 1 | 2019 | 116 | 0.160 |
Why?
|
| Promoter Regions, Genetic | 5 | 2017 | 3101 | 0.160 |
Why?
|
| Rats | 10 | 2019 | 6086 | 0.160 |
Why?
|
| HeLa Cells | 4 | 2013 | 1643 | 0.160 |
Why?
|
| HLA-A Antigens | 2 | 2008 | 102 | 0.160 |
Why?
|
| Foot Deformities, Congenital | 1 | 2017 | 15 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-vav | 1 | 2017 | 10 | 0.150 |
Why?
|
| Expressed Sequence Tags | 5 | 2006 | 101 | 0.150 |
Why?
|
| Protein Structure, Tertiary | 3 | 2011 | 1487 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 1998 | 234 | 0.150 |
Why?
|
| Ankle | 1 | 2017 | 36 | 0.150 |
Why?
|
| Clinical Protocols | 1 | 2020 | 467 | 0.150 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2018 | 132 | 0.150 |
Why?
|
| Forkhead Transcription Factors | 2 | 2024 | 778 | 0.150 |
Why?
|
| Erythropoietin | 1 | 1998 | 205 | 0.150 |
Why?
|
| Child, Preschool | 12 | 2020 | 16273 | 0.150 |
Why?
|
| Genes | 3 | 2006 | 491 | 0.150 |
Why?
|
| Retinoblastoma Protein | 3 | 2008 | 335 | 0.150 |
Why?
|
| Mice, Transgenic | 5 | 2011 | 4143 | 0.150 |
Why?
|
| Base Composition | 4 | 2008 | 92 | 0.150 |
Why?
|
| COS Cells | 2 | 2008 | 377 | 0.150 |
Why?
|
| Aortic Aneurysm, Thoracic | 4 | 2009 | 595 | 0.150 |
Why?
|
| Genetic Markers | 5 | 2020 | 974 | 0.150 |
Why?
|
| Clonal Evolution | 1 | 2019 | 253 | 0.150 |
Why?
|
| Manduca | 1 | 2016 | 4 | 0.150 |
Why?
|
| Transcriptome | 2 | 2017 | 1859 | 0.150 |
Why?
|
| Brain | 4 | 2014 | 4113 | 0.140 |
Why?
|
| Visual Acuity | 1 | 2021 | 873 | 0.140 |
Why?
|
| Diuretics | 1 | 2017 | 170 | 0.140 |
Why?
|
| Neprilysin | 1 | 2016 | 66 | 0.140 |
Why?
|
| Multigene Family | 2 | 2015 | 425 | 0.140 |
Why?
|
| Myelin P2 Protein | 1 | 2016 | 11 | 0.140 |
Why?
|
| Cholesterol, HDL | 2 | 2013 | 341 | 0.140 |
Why?
|
| Longitudinal Studies | 4 | 2023 | 1945 | 0.140 |
Why?
|
| Child | 16 | 2022 | 29154 | 0.140 |
Why?
|
| Cardiomyopathies | 2 | 2016 | 610 | 0.140 |
Why?
|
| Death, Sudden | 1 | 2016 | 59 | 0.140 |
Why?
|
| Orthopedic Procedures | 1 | 2017 | 146 | 0.140 |
Why?
|
| Mutant Proteins | 1 | 2017 | 234 | 0.140 |
Why?
|
| Mobility Limitation | 1 | 2015 | 31 | 0.130 |
Why?
|
| Alanine-tRNA Ligase | 1 | 2015 | 2 | 0.130 |
Why?
|
| Femoral Nerve | 2 | 2005 | 10 | 0.130 |
Why?
|
| Animals, Newborn | 3 | 2011 | 1338 | 0.130 |
Why?
|
| Linkage Disequilibrium | 3 | 2018 | 460 | 0.130 |
Why?
|
| Models, Theoretical | 1 | 2020 | 785 | 0.130 |
Why?
|
| Plant Tumors | 1 | 2015 | 4 | 0.130 |
Why?
|
| Actins | 2 | 2009 | 608 | 0.130 |
Why?
|
| Bees | 1 | 2015 | 32 | 0.130 |
Why?
|
| Receptors, KIR | 2 | 2013 | 62 | 0.130 |
Why?
|
| Lymphatic Diseases | 1 | 1996 | 128 | 0.130 |
Why?
|
| Internet | 2 | 2018 | 706 | 0.130 |
Why?
|
| Triticum | 1 | 2015 | 32 | 0.130 |
Why?
|
| Residence Characteristics | 1 | 2018 | 348 | 0.130 |
Why?
|
| Repressor Proteins | 2 | 2024 | 1664 | 0.130 |
Why?
|
| Diptera | 1 | 2015 | 26 | 0.130 |
Why?
|
| Arthropods | 1 | 2014 | 26 | 0.130 |
Why?
|
| Smoking | 2 | 2024 | 2440 | 0.130 |
Why?
|
| Carcinogenesis | 2 | 2019 | 1026 | 0.130 |
Why?
|
| Pelizaeus-Merzbacher Disease | 1 | 2014 | 20 | 0.130 |
Why?
|
| Drosophila melanogaster | 3 | 2014 | 829 | 0.120 |
Why?
|
| Muscle Proteins | 1 | 2018 | 549 | 0.120 |
Why?
|
| Aged | 17 | 2021 | 70117 | 0.120 |
Why?
|
| Motor Neuron Disease | 2 | 2013 | 16 | 0.120 |
Why?
|
| Amino Acid Sequence | 8 | 2018 | 4233 | 0.120 |
Why?
|
| Peripheral Nerves | 4 | 2006 | 159 | 0.120 |
Why?
|
| Bulbar Palsy, Progressive | 1 | 2013 | 8 | 0.120 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2019 | 413 | 0.120 |
Why?
|
| Antibody Specificity | 2 | 2007 | 334 | 0.120 |
Why?
|
| Heterozygote | 3 | 2016 | 1020 | 0.120 |
Why?
|
| Severity of Illness Index | 5 | 2020 | 4320 | 0.120 |
Why?
|
| Molecular Sequence Annotation | 1 | 2014 | 201 | 0.120 |
Why?
|
| Membrane Potentials | 2 | 2014 | 424 | 0.120 |
Why?
|
| Apolipoproteins A | 1 | 2013 | 42 | 0.110 |
Why?
|
| Gene Expression | 2 | 2016 | 3570 | 0.110 |
Why?
|
| Genes, X-Linked | 1 | 2013 | 66 | 0.110 |
Why?
|
| Transfection | 3 | 2017 | 2944 | 0.110 |
Why?
|
| Myocytes, Cardiac | 2 | 2011 | 764 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 3 | 2 | 2006 | 311 | 0.110 |
Why?
|
| Chromosome Breakage | 3 | 2008 | 226 | 0.110 |
Why?
|
| Fenofibrate | 1 | 2013 | 57 | 0.110 |
Why?
|
| Correction of Hearing Impairment | 1 | 2012 | 2 | 0.110 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 7 | 2008 | 362 | 0.110 |
Why?
|
| Spiral Ganglion | 1 | 2012 | 11 | 0.110 |
Why?
|
| Social Behavior | 1 | 2015 | 306 | 0.110 |
Why?
|
| Persons With Hearing Impairments | 1 | 2012 | 6 | 0.110 |
Why?
|
| DNA Copy Number Variations | 2 | 2018 | 1516 | 0.110 |
Why?
|
| Green Fluorescent Proteins | 2 | 2014 | 694 | 0.110 |
Why?
|
| DNA Transposable Elements | 4 | 2008 | 222 | 0.110 |
Why?
|
| Software | 2 | 2018 | 1321 | 0.110 |
Why?
|
| Computational Biology | 2 | 2014 | 1271 | 0.110 |
Why?
|
| Angiotensin II | 2 | 2018 | 198 | 0.110 |
Why?
|
| Haplotypes | 5 | 2022 | 856 | 0.110 |
Why?
|
| Endometrial Neoplasms | 2 | 2012 | 1341 | 0.110 |
Why?
|
| Nuclear Proteins | 3 | 2019 | 3343 | 0.110 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2013 | 488 | 0.110 |
Why?
|
| Abnormalities, Multiple | 1 | 2019 | 998 | 0.110 |
Why?
|
| DNA Methylation | 3 | 2019 | 2669 | 0.110 |
Why?
|
| Sensory Receptor Cells | 1 | 2013 | 141 | 0.110 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2013 | 144 | 0.100 |
Why?
|
| Cochlear Implants | 1 | 2012 | 40 | 0.100 |
Why?
|
| Cochlear Implantation | 1 | 2012 | 45 | 0.100 |
Why?
|
| Mutant Chimeric Proteins | 2 | 2008 | 24 | 0.100 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2013 | 235 | 0.100 |
Why?
|
| Kv1.2 Potassium Channel | 2 | 2001 | 16 | 0.100 |
Why?
|
| Spectral Karyotyping | 1 | 2011 | 13 | 0.100 |
Why?
|
| Class Ia Phosphatidylinositol 3-Kinase | 1 | 2011 | 29 | 0.100 |
Why?
|
| Behavior, Animal | 1 | 2015 | 709 | 0.100 |
Why?
|
| Kv1.1 Potassium Channel | 2 | 2001 | 39 | 0.100 |
Why?
|
| Hemostasis | 1 | 2012 | 109 | 0.100 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 2 | 2001 | 101 | 0.100 |
Why?
|
| Immunohistochemistry | 5 | 2010 | 7548 | 0.100 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2012 | 1064 | 0.100 |
Why?
|
| Biophysics | 1 | 2011 | 111 | 0.100 |
Why?
|
| Adenocarcinoma | 2 | 2024 | 7789 | 0.100 |
Why?
|
| Contig Mapping | 4 | 2006 | 61 | 0.100 |
Why?
|
| Desmosomes | 2 | 2010 | 28 | 0.100 |
Why?
|
| Xenopus | 1 | 2011 | 219 | 0.090 |
Why?
|
| HLA-DQ Antigens | 2 | 2007 | 58 | 0.090 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2011 | 151 | 0.090 |
Why?
|
| Spinocerebellar Ataxias | 1 | 2013 | 233 | 0.090 |
Why?
|
| Ankyrins | 2 | 2001 | 104 | 0.090 |
Why?
|
| Neutropenia | 1 | 1995 | 968 | 0.090 |
Why?
|
| Family Health | 2 | 2009 | 325 | 0.090 |
Why?
|
| Potassium Channels | 2 | 2001 | 162 | 0.090 |
Why?
|
| Dyslipidemias | 1 | 2013 | 235 | 0.090 |
Why?
|
| RNA, Messenger | 7 | 2017 | 6150 | 0.090 |
Why?
|
| Spinal Cord | 1 | 2013 | 690 | 0.090 |
Why?
|
| Renal Insufficiency | 1 | 2013 | 321 | 0.090 |
Why?
|
| Electric Stimulation | 1 | 2011 | 426 | 0.090 |
Why?
|
| Gene Frequency | 3 | 2022 | 1163 | 0.090 |
Why?
|
| Carcinoma in Situ | 1 | 2013 | 487 | 0.090 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2010 | 69 | 0.090 |
Why?
|
| Immunoprecipitation | 1 | 2011 | 591 | 0.090 |
Why?
|
| HLA-C Antigens | 1 | 2009 | 22 | 0.090 |
Why?
|
| Coculture Techniques | 1 | 2011 | 626 | 0.090 |
Why?
|
| Genome-Wide Association Study | 4 | 2019 | 2265 | 0.090 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2009 | 252 | 0.090 |
Why?
|
| Chromosomes, Human, X | 2 | 2013 | 192 | 0.090 |
Why?
|
| CpG Islands | 3 | 2006 | 633 | 0.090 |
Why?
|
| Oncogenes | 1 | 2012 | 673 | 0.090 |
Why?
|
| Gene Duplication | 3 | 2006 | 421 | 0.090 |
Why?
|
| Serine | 2 | 2013 | 388 | 0.080 |
Why?
|
| Moyamoya Disease | 1 | 2009 | 42 | 0.080 |
Why?
|
| Aged, 80 and over | 9 | 2020 | 29902 | 0.080 |
Why?
|
| Spastic Paraplegia, Hereditary | 1 | 2008 | 30 | 0.080 |
Why?
|
| Cells, Cultured | 4 | 2011 | 5637 | 0.080 |
Why?
|
| Physical Chromosome Mapping | 4 | 2002 | 73 | 0.080 |
Why?
|
| Infant | 5 | 2020 | 13310 | 0.080 |
Why?
|
| Adenocarcinoma, Bronchiolo-Alveolar | 1 | 2008 | 74 | 0.080 |
Why?
|
| Family | 3 | 2018 | 736 | 0.080 |
Why?
|
| Tribolium | 1 | 2008 | 7 | 0.080 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2009 | 611 | 0.080 |
Why?
|
| Cation Transport Proteins | 1 | 2010 | 199 | 0.080 |
Why?
|
| Ornithine Carbamoyltransferase | 1 | 1988 | 22 | 0.080 |
Why?
|
| Cross-Sectional Studies | 4 | 2023 | 4314 | 0.080 |
Why?
|
| Venous Thrombosis | 1 | 2012 | 384 | 0.080 |
Why?
|
| HLA Antigens | 2 | 2007 | 546 | 0.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2021 | 8873 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 2 | 2011 | 6942 | 0.080 |
Why?
|
| Glutamic Acid | 1 | 2009 | 309 | 0.080 |
Why?
|
| Pan troglodytes | 2 | 2006 | 207 | 0.080 |
Why?
|
| Microsatellite Repeats | 2 | 2008 | 575 | 0.080 |
Why?
|
| Chromosome Inversion | 3 | 2006 | 182 | 0.080 |
Why?
|
| DNA | 2 | 2006 | 2693 | 0.080 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2007 | 110 | 0.080 |
Why?
|
| Adenosine Triphosphatases | 1 | 2010 | 435 | 0.080 |
Why?
|
| Genotyping Techniques | 2 | 2018 | 166 | 0.080 |
Why?
|
| Time Factors | 6 | 2020 | 12926 | 0.070 |
Why?
|
| Cell Line, Tumor | 5 | 2021 | 14551 | 0.070 |
Why?
|
| Genes, Neoplasm | 1 | 2008 | 324 | 0.070 |
Why?
|
| Sequence Alignment | 4 | 2013 | 844 | 0.070 |
Why?
|
| Carcinoma | 1 | 2019 | 2578 | 0.070 |
Why?
|
| Neurologic Examination | 2 | 2020 | 245 | 0.070 |
Why?
|
| Conserved Sequence | 2 | 2005 | 469 | 0.070 |
Why?
|
| Myosin Heavy Chains | 1 | 2007 | 128 | 0.070 |
Why?
|
| Hominidae | 1 | 2006 | 37 | 0.070 |
Why?
|
| Cerebral Cortex | 1 | 2011 | 621 | 0.070 |
Why?
|
| Desmoplakins | 1 | 2006 | 22 | 0.070 |
Why?
|
| Cohort Studies | 5 | 2020 | 9244 | 0.070 |
Why?
|
| Central Nervous System | 2 | 2017 | 436 | 0.070 |
Why?
|
| Oligodendroglia | 1 | 2007 | 96 | 0.070 |
Why?
|
| Short Interspersed Nucleotide Elements | 1 | 2006 | 27 | 0.070 |
Why?
|
| Gene Rearrangement | 4 | 2015 | 783 | 0.070 |
Why?
|
| Cell Adhesion Molecules | 2 | 2017 | 577 | 0.070 |
Why?
|
| Biomarkers | 1 | 2017 | 5047 | 0.070 |
Why?
|
| DNA, Fungal | 3 | 1995 | 127 | 0.070 |
Why?
|
| Models, Molecular | 5 | 2010 | 1732 | 0.070 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2021 | 4757 | 0.070 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2011 | 986 | 0.070 |
Why?
|
| Food, Genetically Modified | 1 | 2005 | 6 | 0.070 |
Why?
|
| Codon, Terminator | 1 | 2005 | 42 | 0.070 |
Why?
|
| In Vitro Techniques | 2 | 2019 | 1618 | 0.070 |
Why?
|
| Threonine | 1 | 2006 | 161 | 0.070 |
Why?
|
| Introns | 3 | 2017 | 432 | 0.070 |
Why?
|
| Selenoproteins | 2 | 2015 | 17 | 0.070 |
Why?
|
| Genetic Linkage | 5 | 2005 | 512 | 0.070 |
Why?
|
| HLA-DR Antigens | 1 | 2005 | 173 | 0.070 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2001 | 1498 | 0.070 |
Why?
|
| Methionine | 1 | 2006 | 159 | 0.070 |
Why?
|
| Biotechnology | 1 | 2005 | 63 | 0.070 |
Why?
|
| Biological Evolution | 1 | 2006 | 278 | 0.070 |
Why?
|
| Neoplasm Invasiveness | 1 | 2013 | 3981 | 0.070 |
Why?
|
| Mutagenesis, Insertional | 1 | 2006 | 218 | 0.060 |
Why?
|
| Myelin-Associated Glycoprotein | 2 | 2001 | 17 | 0.060 |
Why?
|
| Prospective Studies | 4 | 2023 | 12873 | 0.060 |
Why?
|
| Vascular Diseases | 1 | 2007 | 246 | 0.060 |
Why?
|
| Larva | 2 | 2016 | 274 | 0.060 |
Why?
|
| Gene Expression Regulation | 4 | 2019 | 4053 | 0.060 |
Why?
|
| Public Opinion | 1 | 2005 | 83 | 0.060 |
Why?
|
| Reproducibility of Results | 3 | 2024 | 6009 | 0.060 |
Why?
|
| Amino Acid Motifs | 1 | 2005 | 392 | 0.060 |
Why?
|
| Tissue Donors | 1 | 2009 | 769 | 0.060 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2011 | 1678 | 0.060 |
Why?
|
| Rats, Inbred BN | 1 | 2004 | 34 | 0.060 |
Why?
|
| Cysteine | 1 | 2005 | 214 | 0.060 |
Why?
|
| Motor Neurons | 1 | 2005 | 138 | 0.060 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2007 | 630 | 0.060 |
Why?
|
| Microscopy, Electron | 2 | 2001 | 600 | 0.060 |
Why?
|
| Cell Count | 1 | 2005 | 508 | 0.060 |
Why?
|
| Tissue Distribution | 1 | 2005 | 875 | 0.060 |
Why?
|
| Bupropion | 1 | 2024 | 76 | 0.060 |
Why?
|
| Italy | 1 | 2024 | 236 | 0.060 |
Why?
|
| DNA, Ribosomal | 2 | 1995 | 103 | 0.060 |
Why?
|
| Glycine | 1 | 2005 | 289 | 0.060 |
Why?
|
| Euchromatin | 1 | 2002 | 15 | 0.060 |
Why?
|
| Histocompatibility Testing | 3 | 2013 | 447 | 0.060 |
Why?
|
| Factor Analysis, Statistical | 1 | 2024 | 356 | 0.060 |
Why?
|
| Scotoma | 1 | 2022 | 21 | 0.060 |
Why?
|
| Sequence Deletion | 1 | 2006 | 875 | 0.050 |
Why?
|
| Operon | 1 | 1982 | 53 | 0.050 |
Why?
|
| Yeasts | 1 | 1982 | 74 | 0.050 |
Why?
|
| Chromosomes, Fungal | 2 | 2000 | 44 | 0.050 |
Why?
|
| Cell Line, Transformed | 2 | 2014 | 394 | 0.050 |
Why?
|
| Biomarkers, Tumor | 1 | 2021 | 10331 | 0.050 |
Why?
|
| Databases, Genetic | 2 | 2016 | 745 | 0.050 |
Why?
|
| Vitamin K Epoxide Reductases | 1 | 2022 | 7 | 0.050 |
Why?
|
| Models, Animal | 1 | 2005 | 664 | 0.050 |
Why?
|
| Aging | 4 | 2016 | 1582 | 0.050 |
Why?
|
| Adherens Junctions | 1 | 2001 | 20 | 0.050 |
Why?
|
| Receptors, Odorant | 2 | 2014 | 47 | 0.050 |
Why?
|
| Headache | 1 | 2022 | 163 | 0.050 |
Why?
|
| Contactins | 1 | 2001 | 5 | 0.050 |
Why?
|
| Rats, Inbred BB | 1 | 2001 | 8 | 0.050 |
Why?
|
| Carcinogenicity Tests | 1 | 2021 | 70 | 0.050 |
Why?
|
| Collagen Type IV | 1 | 2022 | 108 | 0.050 |
Why?
|
| Syndrome | 2 | 2019 | 1351 | 0.050 |
Why?
|
| Ambulatory Care Facilities | 1 | 2024 | 289 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2022 | 317 | 0.050 |
Why?
|
| Actin Cytoskeleton | 1 | 2001 | 82 | 0.050 |
Why?
|
| Chronic Disease | 2 | 1997 | 1819 | 0.050 |
Why?
|
| Wheelchairs | 1 | 2020 | 27 | 0.050 |
Why?
|
| Penetrance | 2 | 2016 | 126 | 0.050 |
Why?
|
| Nerve Growth Factors | 1 | 2001 | 109 | 0.050 |
Why?
|
| Autoantigens | 1 | 2022 | 234 | 0.050 |
Why?
|
| Orthotic Devices | 1 | 2020 | 20 | 0.050 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2008 | 962 | 0.050 |
Why?
|
| Sodium Channels | 1 | 2001 | 109 | 0.050 |
Why?
|
| Coronary Artery Disease | 1 | 2009 | 1011 | 0.050 |
Why?
|
| Receptors, Cell Surface | 2 | 2001 | 862 | 0.050 |
Why?
|
| Alaska | 1 | 2020 | 8 | 0.050 |
Why?
|
| Alaska Natives | 1 | 2020 | 3 | 0.050 |
Why?
|
| Myelin Proteolipid Protein | 1 | 2000 | 25 | 0.050 |
Why?
|
| Vision Disorders | 1 | 2022 | 245 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2001 | 169 | 0.050 |
Why?
|
| Stroke | 1 | 2009 | 1144 | 0.050 |
Why?
|
| Liver Transplantation | 1 | 2009 | 1112 | 0.050 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2010 | 997 | 0.050 |
Why?
|
| Lac Operon | 1 | 2000 | 122 | 0.050 |
Why?
|
| Germ Cells | 1 | 2022 | 335 | 0.050 |
Why?
|
| Genes, Recessive | 1 | 2020 | 200 | 0.050 |
Why?
|
| Indians, North American | 1 | 2020 | 87 | 0.050 |
Why?
|
| Cloning, Molecular | 2 | 2001 | 1213 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2000 | 135 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2001 | 259 | 0.050 |
Why?
|
| Tangier Disease | 1 | 1999 | 3 | 0.050 |
Why?
|
| RNA Splice Sites | 2 | 2014 | 111 | 0.040 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2022 | 2232 | 0.040 |
Why?
|
| Chromosomes, Artificial, Bacterial | 3 | 2008 | 129 | 0.040 |
Why?
|
| Saccharomyces cerevisiae | 2 | 2000 | 621 | 0.040 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2000 | 129 | 0.040 |
Why?
|
| DNA Fingerprinting | 2 | 2001 | 167 | 0.040 |
Why?
|
| Drosophila | 1 | 2005 | 839 | 0.040 |
Why?
|
| Alternative Splicing | 2 | 2001 | 584 | 0.040 |
Why?
|
| Centromere | 3 | 2005 | 97 | 0.040 |
Why?
|
| Transcription Factors | 3 | 2017 | 5270 | 0.040 |
Why?
|
| Melanoma | 1 | 1996 | 5317 | 0.040 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 14289 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2022 | 672 | 0.040 |
Why?
|
| Caenorhabditis elegans | 1 | 2000 | 268 | 0.040 |
Why?
|
| Cadherins | 1 | 2001 | 660 | 0.040 |
Why?
|
| RNA, Untranslated | 2 | 2014 | 237 | 0.040 |
Why?
|
| Search Engine | 1 | 2018 | 21 | 0.040 |
Why?
|
| Genes, Homeobox | 1 | 1998 | 147 | 0.040 |
Why?
|
| United States | 3 | 2024 | 15433 | 0.040 |
Why?
|
| Macaca mulatta | 2 | 2013 | 717 | 0.040 |
Why?
|
| CCAAT-Enhancer-Binding Protein-delta | 1 | 2017 | 13 | 0.040 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2000 | 244 | 0.040 |
Why?
|
| Spermatozoa | 1 | 2000 | 315 | 0.040 |
Why?
|
| Neurilemmoma | 1 | 2019 | 127 | 0.040 |
Why?
|
| Sacrum | 1 | 1998 | 132 | 0.040 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2019 | 82 | 0.040 |
Why?
|
| Mucous Membrane | 1 | 2019 | 271 | 0.040 |
Why?
|
| ras Proteins | 2 | 2013 | 770 | 0.040 |
Why?
|
| Oocytes | 1 | 2000 | 414 | 0.040 |
Why?
|
| Tissue Banks | 1 | 2018 | 55 | 0.040 |
Why?
|
| Uric Acid | 1 | 2017 | 75 | 0.040 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 1999 | 299 | 0.040 |
Why?
|
| Bone Diseases | 1 | 1998 | 143 | 0.040 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2009 | 198 | 0.040 |
Why?
|
| GTP-Binding Proteins | 1 | 1998 | 321 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 13 | 2 | 2008 | 141 | 0.040 |
Why?
|
| HLA-DQ beta-Chains | 2 | 2007 | 34 | 0.040 |
Why?
|
| Pupa | 1 | 2016 | 22 | 0.040 |
Why?
|
| Translocation, Genetic | 1 | 2022 | 1245 | 0.040 |
Why?
|
| Consent Forms | 1 | 2016 | 25 | 0.040 |
Why?
|
| Coroners and Medical Examiners | 1 | 2016 | 18 | 0.040 |
Why?
|
| Potassium | 1 | 2017 | 329 | 0.040 |
Why?
|
| Telomere | 3 | 2008 | 505 | 0.040 |
Why?
|
| Germany | 2 | 2009 | 111 | 0.040 |
Why?
|
| Vitiligo | 1 | 1996 | 14 | 0.040 |
Why?
|
| Diagnosis | 1 | 2016 | 34 | 0.040 |
Why?
|
| User-Computer Interface | 1 | 2018 | 286 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 1077 | 0.030 |
Why?
|
| Pancreatic Neoplasms | 1 | 2013 | 5061 | 0.030 |
Why?
|
| Collagen | 1 | 1999 | 752 | 0.030 |
Why?
|
| DNA, Recombinant | 2 | 1988 | 121 | 0.030 |
Why?
|
| Retrospective Studies | 4 | 2024 | 37905 | 0.030 |
Why?
|
| Glycoproteins | 1 | 1999 | 747 | 0.030 |
Why?
|
| Bee Venoms | 1 | 2015 | 9 | 0.030 |
Why?
|
| Chemoreceptor Cells | 1 | 2015 | 16 | 0.030 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2013 | 1331 | 0.030 |
Why?
|
| Isoenzymes | 1 | 2018 | 614 | 0.030 |
Why?
|
| Interspersed Repetitive Sequences | 1 | 2015 | 33 | 0.030 |
Why?
|
| Confidentiality | 1 | 2016 | 127 | 0.030 |
Why?
|
| Circadian Rhythm Signaling Peptides and Proteins | 1 | 2014 | 9 | 0.030 |
Why?
|
| Sequence Homology | 1 | 2015 | 71 | 0.030 |
Why?
|
| Chromosome Aberrations | 1 | 2022 | 1960 | 0.030 |
Why?
|
| Trans-Activators | 1 | 2001 | 1555 | 0.030 |
Why?
|
| Allografts | 1 | 2017 | 650 | 0.030 |
Why?
|
| Disclosure | 1 | 2016 | 181 | 0.030 |
Why?
|
| Adaptation, Biological | 1 | 2015 | 49 | 0.030 |
Why?
|
| Sexual Behavior, Animal | 1 | 2015 | 65 | 0.030 |
Why?
|
| Sex Chromosomes | 1 | 2014 | 43 | 0.030 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 2005 | 354 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 2 | 2006 | 3203 | 0.030 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2015 | 189 | 0.030 |
Why?
|
| Position-Specific Scoring Matrices | 1 | 2014 | 9 | 0.030 |
Why?
|
| Genome, Mitochondrial | 1 | 2014 | 37 | 0.030 |
Why?
|
| Models, Genetic | 2 | 2015 | 1113 | 0.030 |
Why?
|
| RNA | 2 | 2013 | 1013 | 0.030 |
Why?
|
| Inflammation | 2 | 2012 | 2522 | 0.030 |
Why?
|
| Evoked Potentials, Visual | 1 | 2014 | 39 | 0.030 |
Why?
|
| Transcription Initiation Site | 1 | 2014 | 51 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2017 | 417 | 0.030 |
Why?
|
| Amyloid beta-Peptides | 1 | 2016 | 246 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2019 | 677 | 0.030 |
Why?
|
| Open Reading Frames | 1 | 2015 | 250 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2009 | 14889 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2001 | 2508 | 0.030 |
Why?
|
| Nucleotide Motifs | 1 | 2014 | 62 | 0.030 |
Why?
|
| X Chromosome | 3 | 2002 | 339 | 0.030 |
Why?
|
| ROC Curve | 1 | 2017 | 1183 | 0.030 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2021 | 1283 | 0.030 |
Why?
|
| Radiography | 1 | 2019 | 1904 | 0.030 |
Why?
|
| Action Potentials | 1 | 1997 | 560 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2021 | 5395 | 0.030 |
Why?
|
| Mechanoreceptors | 1 | 2013 | 28 | 0.030 |
Why?
|
| Riboflavin | 1 | 2013 | 26 | 0.030 |
Why?
|
| RNA Editing | 1 | 2014 | 92 | 0.030 |
Why?
|
| Proprioception | 1 | 2013 | 21 | 0.030 |
Why?
|
| Afferent Pathways | 1 | 2013 | 64 | 0.030 |
Why?
|
| Cell Proliferation | 2 | 2021 | 7226 | 0.030 |
Why?
|
| Species Specificity | 1 | 2015 | 777 | 0.030 |
Why?
|
| Human Genome Project | 2 | 2006 | 64 | 0.030 |
Why?
|
| Cats | 1 | 2013 | 166 | 0.030 |
Why?
|
| Phosphorylation | 2 | 2012 | 4804 | 0.030 |
Why?
|
| Apolipoprotein A-V | 1 | 2013 | 21 | 0.030 |
Why?
|
| Hormones | 1 | 2014 | 266 | 0.030 |
Why?
|
| Touch | 1 | 2013 | 71 | 0.030 |
Why?
|
| Opportunistic Infections | 1 | 1995 | 223 | 0.030 |
Why?
|
| Apolipoprotein A-I | 1 | 2013 | 84 | 0.030 |
Why?
|
| Kidney | 1 | 2022 | 2146 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 2016 | 8223 | 0.030 |
Why?
|
| Carnitine | 1 | 2013 | 94 | 0.030 |
Why?
|
| Prognosis | 2 | 2021 | 21713 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2013 | 2488 | 0.030 |
Why?
|
| Cell Line | 2 | 2017 | 5114 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 1998 | 1143 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2021 | 3821 | 0.030 |
Why?
|
| Audiometry, Pure-Tone | 1 | 2012 | 32 | 0.030 |
Why?
|
| Ethics, Medical | 1 | 2016 | 442 | 0.030 |
Why?
|
| Auditory Threshold | 1 | 2012 | 26 | 0.030 |
Why?
|
| Loss of Heterozygosity | 2 | 2007 | 602 | 0.030 |
Why?
|
| Vitamins | 1 | 2013 | 157 | 0.030 |
Why?
|
| Candidiasis | 1 | 1995 | 262 | 0.030 |
Why?
|
| Leucine | 1 | 2014 | 352 | 0.030 |
Why?
|
| Proline | 1 | 2013 | 130 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2013 | 392 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2012 | 6100 | 0.030 |
Why?
|
| Acoustic Stimulation | 1 | 2012 | 118 | 0.030 |
Why?
|
| RNA Splicing | 1 | 2014 | 370 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2012 | 86 | 0.030 |
Why?
|
| DNA, Complementary | 2 | 2006 | 869 | 0.030 |
Why?
|
| Precision Medicine | 1 | 2020 | 1154 | 0.030 |
Why?
|
| Systems Biology | 1 | 2012 | 112 | 0.030 |
Why?
|
| Dogs | 1 | 2013 | 1155 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2014 | 7702 | 0.030 |
Why?
|
| Recombination, Genetic | 2 | 2006 | 613 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2014 | 1053 | 0.030 |
Why?
|
| Apoptosis | 2 | 2021 | 7591 | 0.030 |
Why?
|
| Dementia | 1 | 2016 | 453 | 0.020 |
Why?
|
| Cost of Illness | 1 | 2014 | 498 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 4971 | 0.020 |
Why?
|
| Minisatellite Repeats | 1 | 2011 | 51 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2016 | 769 | 0.020 |
Why?
|
| Serine Endopeptidases | 1 | 2012 | 275 | 0.020 |
Why?
|
| Blotting, Southern | 1 | 1991 | 406 | 0.020 |
Why?
|
| Arginine | 1 | 2014 | 500 | 0.020 |
Why?
|
| Chromosome Banding | 1 | 2011 | 256 | 0.020 |
Why?
|
| Proteins | 2 | 2014 | 1963 | 0.020 |
Why?
|
| Health Care Costs | 1 | 2016 | 674 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2021 | 2864 | 0.020 |
Why?
|
| Skin | 1 | 2016 | 1259 | 0.020 |
Why?
|
| Attitude of Health Personnel | 1 | 2017 | 918 | 0.020 |
Why?
|
| Menkes Kinky Hair Syndrome | 1 | 2010 | 5 | 0.020 |
Why?
|
| Triglycerides | 1 | 2013 | 603 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2017 | 2450 | 0.020 |
Why?
|
| Logistic Models | 1 | 2017 | 3441 | 0.020 |
Why?
|
| Xenopus Proteins | 1 | 2011 | 185 | 0.020 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2011 | 190 | 0.020 |
Why?
|
| Cell Cycle Proteins | 2 | 2014 | 2045 | 0.020 |
Why?
|
| Protein Kinases | 1 | 2014 | 874 | 0.020 |
Why?
|
| Axotomy | 2 | 2000 | 10 | 0.020 |
Why?
|
| Copper-transporting ATPases | 1 | 2010 | 44 | 0.020 |
Why?
|
| Ligands | 1 | 2013 | 995 | 0.020 |
Why?
|
| Genetic Complementation Test | 1 | 2010 | 125 | 0.020 |
Why?
|
| Surgeons | 1 | 2017 | 519 | 0.020 |
Why?
|
| Amino Acids | 1 | 2013 | 728 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2014 | 898 | 0.020 |
Why?
|
| Genome, Fungal | 2 | 2000 | 54 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2015 | 854 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 1323 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 4744 | 0.020 |
Why?
|
| Prevalence | 1 | 2017 | 3260 | 0.020 |
Why?
|
| Locus Control Region | 1 | 2008 | 15 | 0.020 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2011 | 521 | 0.020 |
Why?
|
| Algorithms | 2 | 2016 | 3890 | 0.020 |
Why?
|
| Copper | 1 | 2010 | 165 | 0.020 |
Why?
|
| Proto-Oncogenes | 1 | 2008 | 202 | 0.020 |
Why?
|
| DNA Restriction Enzymes | 1 | 1988 | 117 | 0.020 |
Why?
|
| Growth and Development | 1 | 2008 | 28 | 0.020 |
Why?
|
| HLA-A24 Antigen | 1 | 2007 | 13 | 0.020 |
Why?
|
| Taste | 1 | 2008 | 50 | 0.020 |
Why?
|
| Genetic Therapy | 1 | 2016 | 1616 | 0.020 |
Why?
|
| Survival Rate | 1 | 2021 | 12221 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2014 | 1439 | 0.020 |
Why?
|
| Untranslated Regions | 1 | 2007 | 15 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2012 | 2307 | 0.020 |
Why?
|
| Insecticides | 1 | 2008 | 49 | 0.020 |
Why?
|
| Oogenesis | 1 | 2008 | 71 | 0.020 |
Why?
|
| Liver | 1 | 2018 | 2961 | 0.020 |
Why?
|
| Evoked Potentials | 1 | 2008 | 190 | 0.020 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2007 | 28 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 2013 | 1910 | 0.020 |
Why?
|
| DNA Primers | 1 | 2010 | 1399 | 0.020 |
Why?
|
| Body Patterning | 1 | 2008 | 212 | 0.020 |
Why?
|
| Neurotransmitter Agents | 1 | 2008 | 159 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1988 | 542 | 0.020 |
Why?
|
| Vision, Ocular | 1 | 2008 | 157 | 0.020 |
Why?
|
| Homozygote | 1 | 2009 | 717 | 0.020 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2008 | 200 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2011 | 1489 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2009 | 842 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2013 | 1648 | 0.020 |
Why?
|
| Intercellular Junctions | 1 | 2006 | 54 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2012 | 2216 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2001 | 2063 | 0.020 |
Why?
|
| Leukemia | 1 | 1995 | 1635 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2018 | 32848 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2008 | 769 | 0.020 |
Why?
|
| HLA-DRB3 Chains | 1 | 2005 | 4 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2008 | 11538 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2007 | 644 | 0.020 |
Why?
|
| HLA-DQ alpha-Chains | 1 | 2005 | 23 | 0.020 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2007 | 137 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2008 | 829 | 0.020 |
Why?
|
| HLA-DRB1 Chains | 1 | 2005 | 82 | 0.020 |
Why?
|
| Dosage Compensation, Genetic | 1 | 2005 | 63 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2006 | 254 | 0.020 |
Why?
|
| Chromosomes, Human, Y | 1 | 2005 | 53 | 0.020 |
Why?
|
| Crossing Over, Genetic | 1 | 2005 | 56 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2012 | 2803 | 0.020 |
Why?
|
| Urinary Bladder | 1 | 2008 | 575 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 1996 | 2967 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2017 | 5687 | 0.020 |
Why?
|
| Patient Selection | 1 | 2012 | 2055 | 0.020 |
Why?
|
| Retroelements | 1 | 2004 | 47 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2011 | 1546 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2008 | 15694 | 0.020 |
Why?
|
| Chromosomes, Mammalian | 1 | 2004 | 59 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2013 | 4988 | 0.020 |
Why?
|
| Proteome | 1 | 2008 | 561 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2012 | 2022 | 0.010 |
Why?
|
| Genetics, Medical | 1 | 2005 | 143 | 0.010 |
Why?
|
| Switzerland | 1 | 2003 | 21 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2011 | 2054 | 0.010 |
Why?
|
| Killer Cells, Natural | 1 | 2009 | 904 | 0.010 |
Why?
|
| Genetic Engineering | 1 | 2005 | 288 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2012 | 2359 | 0.010 |
Why?
|
| RNA Interference | 1 | 2008 | 1408 | 0.010 |
Why?
|
| Aorta | 1 | 2007 | 692 | 0.010 |
Why?
|
| Lod Score | 1 | 2003 | 157 | 0.010 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2004 | 220 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2006 | 741 | 0.010 |
Why?
|
| Immunophenotyping | 1 | 2007 | 1681 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 2006 | 483 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2004 | 483 | 0.010 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2005 | 467 | 0.010 |
Why?
|
| DNA, Mitochondrial | 1 | 2004 | 311 | 0.010 |
Why?
|
| Nerve Crush | 1 | 2001 | 9 | 0.010 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2003 | 315 | 0.010 |
Why?
|
| Marfan Syndrome | 1 | 2003 | 142 | 0.010 |
Why?
|
| Sequence Tagged Sites | 1 | 2001 | 33 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 2001 | 130 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2013 | 3552 | 0.010 |
Why?
|
| RNA-Induced Silencing Complex | 1 | 2000 | 26 | 0.010 |
Why?
|
| Testis | 1 | 2005 | 717 | 0.010 |
Why?
|
| Genomic Library | 1 | 2000 | 41 | 0.010 |
Why?
|
| DNA Repair | 1 | 2008 | 1872 | 0.010 |
Why?
|
| Calcium-Binding Proteins | 1 | 2003 | 545 | 0.010 |
Why?
|
| Argonaute Proteins | 1 | 2000 | 40 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2012 | 3230 | 0.010 |
Why?
|
| Plasmids | 1 | 1982 | 837 | 0.010 |
Why?
|
| Chromosomes, Bacterial | 1 | 2000 | 62 | 0.010 |
Why?
|
| Helminth Proteins | 1 | 2000 | 107 | 0.010 |
Why?
|
| ATP Binding Cassette Transporter 1 | 1 | 1999 | 29 | 0.010 |
Why?
|
| Heart | 1 | 2006 | 1223 | 0.010 |
Why?
|
| Polysaccharide-Lyases | 1 | 1999 | 2 | 0.010 |
Why?
|
| Models, Biological | 1 | 2008 | 3254 | 0.010 |
Why?
|
| Pepsin A | 1 | 1999 | 16 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2001 | 1062 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2001 | 1008 | 0.010 |
Why?
|
| Ascorbic Acid | 1 | 1999 | 131 | 0.010 |
Why?
|
| Fibronectins | 1 | 1999 | 197 | 0.010 |
Why?
|
| Nerve Regeneration | 1 | 1999 | 105 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1999 | 629 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 1999 | 290 | 0.010 |
Why?
|
| Proteoglycans | 1 | 1999 | 259 | 0.010 |
Why?
|
| Spermatogenesis | 1 | 2000 | 308 | 0.010 |
Why?
|
| Antigens, Neoplasm | 1 | 2005 | 1506 | 0.010 |
Why?
|
| Chromosome Deletion | 1 | 1982 | 1005 | 0.010 |
Why?
|
| beta Catenin | 1 | 2001 | 688 | 0.010 |
Why?
|
| Gene Library | 1 | 1998 | 294 | 0.010 |
Why?
|
| Echocardiography | 1 | 2003 | 1182 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2009 | 9180 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 1998 | 327 | 0.010 |
Why?
|
| Receptors, Notch | 1 | 2000 | 383 | 0.010 |
Why?
|
| Heparin | 1 | 1999 | 360 | 0.010 |
Why?
|
| Graft vs Host Disease | 1 | 2007 | 2638 | 0.010 |
Why?
|
| Comorbidity | 1 | 2003 | 2352 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2005 | 4892 | 0.010 |
Why?
|
| Extracellular Matrix | 1 | 1999 | 554 | 0.010 |
Why?
|
| Risk Factors | 1 | 2013 | 17523 | 0.010 |
Why?
|
| Research Design | 1 | 2002 | 1544 | 0.010 |
Why?
|
| Cell Division | 1 | 1999 | 2489 | 0.010 |
Why?
|
| Drosophila Proteins | 1 | 2000 | 858 | 0.010 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 1993 | 122 | 0.010 |
Why?
|